• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保留瓣膜的根部置换术:年龄多大算过大?

Valve-sparing root replacement: How old is too old?

作者信息

Norton Elizabeth L, Wang Yanhua, Patel Parth M, Levine Dov, Binongo Jose, Leshnower Bradley G, Takayama Hiroo, Chen Edward P

机构信息

Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Ga.

Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, Ga.

出版信息

JTCVS Open. 2025 Mar 14;25:10-22. doi: 10.1016/j.xjon.2025.02.020. eCollection 2025 Jun.

DOI:10.1016/j.xjon.2025.02.020
PMID:40631040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12230498/
Abstract

OBJECTIVE

Valve-sparing root replacement (VSRR) is associated with excellent short- and long-term outcomes. Although typically offered in young patients, VSRR is performed over a wide age range, including into the eighth decade of life. This study analyzed the influence of age and preoperative comorbidities on operative outcomes, reoperation, and survival following VSRR.

METHODS

From 2004 to 2021, 780 patients underwent VSRR in an academic database. VSRR was performed using the David V reimplantation technique. A discriminating age cutoff for the effect of age on long-term survival was determined by Contal and O'Quigley methods and patients were divided into 2 groups based on age at time of surgery.

RESULTS

The optimal age cutoff for patients undergoing VSRR was found to be 65 years; 16% were aged 65 years or older at time of surgery. Overall, in-hospital mortality was 1.5% and was significantly higher among the group of patients older than age 65 years (4.1% vs 1.1%; = .03). The cumulative incidence of reoperation of the aortic valve or proximal aorta was similar between the group of patients aged 65 years and older and patients younger than age 65 years (5% vs 6%; = .28). Overall, 10-year survival was 89% and significantly worse among the patients aged 65 years and older (76% vs 92%; < .0001). Age 65 years and older was an independent risk factor for late mortality (hazard ratio, 1.04; 95% CI, 1.01-1.07; = .003).

CONCLUSIONS

VSRR can be performed with low operative mortality and excellent freedom from reoperation across age groups. In patients aged 65 years and older, serious consideration should be given when deciding on VSRR, especially in the setting of aortic dissection.

摘要

目的

保留瓣膜的根部置换术(VSRR)具有出色的短期和长期疗效。尽管VSRR通常适用于年轻患者,但该手术在广泛的年龄范围内开展,包括八十多岁的患者。本研究分析了年龄和术前合并症对VSRR术后手术结局、再次手术和生存情况的影响。

方法

2004年至2021年期间,学术数据库中有780例患者接受了VSRR。采用David V再植入技术进行VSRR。通过Contal和O'Quigley方法确定年龄对长期生存影响的区分年龄界限,并根据手术时的年龄将患者分为两组。

结果

发现接受VSRR患者的最佳年龄界限为65岁;16%的患者手术时年龄在65岁及以上。总体而言,住院死亡率为1.5%,65岁以上患者组的死亡率显著更高(4.1%对1.1%;P = 0.03)。65岁及以上患者组与65岁以下患者组之间主动脉瓣或主动脉近端再次手术的累积发生率相似(5%对6%;P = 0.28)。总体而言,10年生存率为89%,65岁及以上患者的生存率显著更低(76%对92%;P < 0.0001)。65岁及以上是晚期死亡的独立危险因素(风险比,1.04;95%置信区间,1.01 - 1.07;P = 0.003)。

结论

VSRR手术死亡率低,各年龄组再次手术率低。对于65岁及以上的患者,决定是否进行VSRR时应慎重考虑,尤其是在主动脉夹层的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/91128d7e4625/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/e74e5a0cfb4d/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/366423bc3a87/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/e8825a1ca0ae/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/cb4a7b7ba07a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/26d240786f41/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/2b7efe92a115/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/91128d7e4625/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/e74e5a0cfb4d/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/366423bc3a87/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/e8825a1ca0ae/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/cb4a7b7ba07a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/26d240786f41/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/2b7efe92a115/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d0/12230498/91128d7e4625/fx2.jpg

相似文献

1
Valve-sparing root replacement: How old is too old?保留瓣膜的根部置换术:年龄多大算过大?
JTCVS Open. 2025 Mar 14;25:10-22. doi: 10.1016/j.xjon.2025.02.020. eCollection 2025 Jun.
2
Revisiting ascending aortic resection in the elective valve-sparing root replacement: assessing the benefits and necessity of hemiarch replacement at three centres†.重新审视择期保留瓣膜根部置换术中升主动脉切除术:评估三个中心半弓置换术的益处和必要性†
Eur J Cardiothorac Surg. 2025 Feb 4;67(2). doi: 10.1093/ejcts/ezaf006.
3
Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis.马凡综合征主动脉根部疾病的外科治疗:系统评价和荟萃分析。
Heart. 2011 Jun;97(12):955-8. doi: 10.1136/hrt.2010.210286. Epub 2011 Jan 12.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
What Factors Are Associated With Implant Revision in the Treatment of Pathologic Subtrochanteric Femur Fractures?在病理性股骨转子下骨折的治疗中,哪些因素与植入物翻修相关?
Clin Orthop Relat Res. 2025 Mar 1;483(3):473-484. doi: 10.1097/CORR.0000000000003291. Epub 2024 Oct 22.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Valve-sparing aortic root replacement: Long-term variables significantly associated with mortality and morbidity.保留瓣膜的主动脉根部置换术:与死亡率和发病率显著相关的长期变量。
J Thorac Cardiovasc Surg. 2025 Jan;169(1):68-77.e0. doi: 10.1016/j.jtcvs.2023.11.027. Epub 2023 Nov 21.
2
Valve-sparing aortic root replacement-for all patients?保留瓣膜的主动脉根部替换术——适用于所有患者吗?
J Thorac Cardiovasc Surg. 2024 Nov;168(5):1403-1413.e2. doi: 10.1016/j.jtcvs.2023.08.055. Epub 2023 Sep 9.
3
Valve-sparing aortic root replacement versus composite valve graft with bioprosthesis in patients under age 50.
50 岁以下患者的保留瓣膜主动脉根部替换术与带生物瓣的复合瓣叶移植物置换术。
J Thorac Cardiovasc Surg. 2024 Oct;168(4):992-1002.e1. doi: 10.1016/j.jtcvs.2023.07.016. Epub 2023 Jul 21.
4
Bentall versus valve-sparing aortic root replacement for root pathology with moderate-to-severe aortic insufficiency: a propensity-matched analysis.主动脉根部病变合并中重度主动脉瓣关闭不全的 Bentall 术与保留瓣膜的主动脉根部置换术:倾向性匹配分析。
Eur J Cardiothorac Surg. 2023 Aug 1;64(2). doi: 10.1093/ejcts/ezad231.
5
Mid-term outcomes of stentless Bio-Bentall vs. David Reimplantation for aortic root replacement.无支架生物主动脉瓣环与 David 重植入术在主动脉根部置换术中的中期结果比较。
J Card Surg. 2022 Apr;37(4):781-788. doi: 10.1111/jocs.16271. Epub 2022 Jan 28.
6
Valve-Sparing Root Replacement Versus Bio-Bentall: Inverse Propensity Weighting of 796 Patients.保留瓣膜的根部置换术与生物Bentall手术:796例患者的逆倾向加权分析
Ann Thorac Surg. 2022 May;113(5):1529-1535. doi: 10.1016/j.athoracsur.2021.05.044. Epub 2021 Jun 8.
7
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
8
Early and Late Results After David vs Bentall Procedure: A Propensity Matched Analysis.David 与 Bentall 手术后的早期和晚期结果:倾向匹配分析。
Ann Thorac Surg. 2020 Jul;110(1):120-126. doi: 10.1016/j.athoracsur.2019.10.020. Epub 2019 Nov 28.
9
Valve-sparing root replacement in patients with bicuspid versus tricuspid aortic valves.二叶式主动脉瓣与三叶式主动脉瓣患者的保留瓣膜根部置换术。
J Thorac Cardiovasc Surg. 2019 Jul;158(1):1-9. doi: 10.1016/j.jtcvs.2018.10.151. Epub 2018 Nov 24.
10
Durability and safety of David V valve-sparing root replacement in acute type A aortic dissection.David V 瓣膜保留型主动脉根部替换术治疗急性 A 型主动脉夹层的耐久性和安全性。
J Thorac Cardiovasc Surg. 2019 Jan;157(1):14-23.e1. doi: 10.1016/j.jtcvs.2018.10.059. Epub 2018 Oct 23.